ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 154751 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 154751; 2) Community: the network communities that were significantly associated with the response to NSC 154751; 3) Molecule: the relationships between components within communities and NSC 154751; 4) MDR: the compounds that were significantly associated with the NSC 154751.

NSC Compound Enrichment Correlation
NSC 163062 TRIPTOLIDE 0.0110679092462696 0.20037095
NSC 177382 TUNICAMYCIN 0.0110679092462696 -0.095358804
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0110679092462696 0.46829682
NSC 281613 Ethanol, 2,2'-[[4-[[[3-chloro-4-(2-phenyl-4-thiazolyl)phenyl]imino]methyl]-3-methylphenyl]imino]bis-, dimethanesulfonate (ester) 0.0110679092462696 0.3360367
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0110679092462696 0.43888601
NSC 34533 Fulcin 0.0110679092462696 0.54350827
NSC 373355 Saframycin R 0.0110679092462696 0.024887219
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0110679092462696 0.37472205
NSC 406666 Null 0.0110679092462696 0.28615648
NSC 529108 4-Fluoro-D,L-tryptophan 0.0110679092462696 0.54135958
Total:146  Current:49    [First] [Prev] [Next] [Last]